
A statement hours after the company reported promising interim phase 3 data stated the Data Safety and Monitoring Board believes they included outdated data “which may have provided an incomplete view of the efficacy data.”

A statement hours after the company reported promising interim phase 3 data stated the Data Safety and Monitoring Board believes they included outdated data “which may have provided an incomplete view of the efficacy data.”

Filmmaker Bill Mudge has released his new documentary, Beating Superbugs: Can We Win? It looks at emerging technologies designed to develop new therapies to combat antibiotic resistance (ABR).

Levels of interferon gene activity were much lower in those with the missense mutation.

Regeneron announces results from Phase 3 trial of its monoclonal antibody treatment.

The challenges of explaining new guidance, like that for school-aged children, is so important to ensure people understand the science and reasoning behind it, but also why following it is important.

Facilities in Connecticut had an outbreak prior to vaccinating their residents, which in turn controlled the spread effectively.

Reproduction number should govern allocation of the shot, researchers say.

New polls shows confidence in AstraZeneca vaccine plummets in Europe.

The small country's emphasis on accessible testing provided more up-to-date tracking, and opportunity for research into reinfection risk.

After a year of setbacks, AZD1222 has been associated with 100% prevention of severe COVID-19 in US trial participants. Could emergency authorization come soon?

The Infectious Diseases Society of America (IDSA) discusses some of the new treatments show measurable impact on severe disease and death.

8% of ischemic stroke patients had atrial fibrillation, while 9% of those without stroke also had atrial fibrillation.

COVID-19 vaccine development demanded an adults-first approach. A year in, children are being invited to participate in trials in hopes of getting the pediatric population vaccinated later this year.

Machine learning is a promising and potentially powerful technique for detection and prognosis of disease.

Regardless of symptom status, the rate of participants positive for pan-immunoglobulins with neutralizing antibodies at baseline remained stable throughout 2020.

Approaches that measure the indirect effect of the virus on the host may offer complementary solutions in clinical or mass testing.

New drugs likely won’t meet resistance challenges ahead, authors say.

Getting kids back in classrooms is crucial, and it can be done with planning and forethought.

The US was poised in many ways to handle a public health emergency, but the attempt was largely a failure. What happened and how can we push forward?

No causative link has been established between the shot and blood clots or severe bleeding.

Ultrasound is known to cause the breaking up of kidney stones and opening the lipid shell of liposome for drug delivery.

Recruitment for a phase 2 trial of a novel antibiotic against Clostridium difficile (C diff) is proceeding after phase 1 demonstrated safety and tolerability.

The new findings support increased protection from reinfection up to 6 months after first testing positive, though older patients are at greater risk of reinfection.

Researchers and clinicians continually failed to connect with the greater public on matters of the pandemic. What drove the divide between the already distanced groups?

To minimalize mouth rinse-associated cytotoxicity, mouth rinse was largely removed from treated viruses by centrifugation prior to infection of cells.

Findings underscore the need to stay on top of emerging mutations through aggressive genomic surveillance.

New World Obesity Foundation report finds higher COVD-19 mortality rates in countries with higher prevalence of obesity.

A 2-dose vaccination regimen did not show protection against mild-to-moderate disease due to the B.1.351 variant.

CT imaging can detect illness in the lungs better than other medical imaging like MRI.